Sheel Bio, a company in the Diversified Commercial Services industry, reported revenue of ₹51 crore and net profit of ₹3.00 crore for the September 2026 quarter.
Sheel Bio. (NSE: SHEEL-SM) closed at ₹57.90 on 20 Nov 2026, down 24.9% over the past year. Its market capitalisation is ₹118 crore and it trades at 7.9 times earnings.
Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.